We’ve all seen the reports: artificial intelligence is here and it will change the way we look at and interact with healthcare. Most recently, Elon Musk made waves in the industry when he announced NeuraLink, his company to explore ways to connect the human brain to a computer interface, has applied to US regulators to start trialling its device on humans.
NeuraLink, however, is not alone. There are several companies in Europe that are taking the lead when it comes to exploring ways to use AI and machine learning in healthcare. We’ve selected three of them that should be on your radar.
Babylon’s mission is to put an accessible and affordable healthcare service in the hands of every person on earth. Using a combination of unique AI technology and medical expertise, Babylon is able to deliver digital health tools in multiple languages and localised for multiple countries.
In some countries, they offer 24-hours-a-day, 7-days-a-week access to a health professional through virtual consultations. Their current technology allows users to instantly learn more about their symptoms through their AI symptom checker and to assess and improve their future health with an AI-powered healthcheck.
The company recently announced it raised $550 million in Series C funding, elevating the company to unicorn status, with a valuation of $2 billion with a total of $635 million raised.
We’ve been working with BIOS since August last year and what a thrill it has been! BIOS is a leading neural engineering startup, creating the open standard hardware and software interface between the human nervous system and AI. They are developing the standards, datasets, tools, and algorithms to enable a new generation of neural treatments to improve the quality of life for millions of people affected by chronic disease.
Their team combines applied materials, machine learning, software, neuroscience in conjunction with the experience of surgeons, clinicians and patients to create a seamless and accessible user experience. BIOS has generated the largest peripheral neural data set in the world and is leading cutting-edge machine learning research in the neuromodulation and bioelectronic medicine fields.
Last December, they raised $4.5 million to grow operations in the UK and expand internationally. More recently, they won The Europas Awards as "Hottest HealthTech Startup" and were also included in Startups 100 2019.
Lifebit is building a cloud-based cognitive system that can reason about DNA data like humans do. Its first product, Deploit, can be used to scale distributed analysis within a team’s own secure data environments and drastically reduce time and costs up to 80%.
The company’s AI Engine is the tool of the future for precision medicine and multi-omics data analysis. By using their federated machine learning platform, users can have access to the insights provided by datasets across the globe, while the data stays where it is, private and secure. This allows algorithms to be trained on huge datasets without worrying about data sharing obstacles. Finally, biomedical data can be shared across organisations to benefit the precision medicine industry, enabling worldwide benefits.
BY RENATA MIRANDA, ACCOUNT MANAGER AT CEW COMMS.